Coronavirus (COVID-19) Update
AmerisourceBergen and our global businesses are highly engaged during the ongoing spread of the novel COVID-19 “Coronavirus."
Specialized care from the start
Acquisition and growthUS Bioservices was acquired by global healthcare solutions leader AmerisourceBergen in 2003. US Bioservices works in collaboration with other AmerisourceBergen business units to enhance patient care, support care in local communities and offer manufacturer partners integrated commercialization solutions. With services ranging from drug distribution and niche premium logistics to reimbursement and pharmaceutical consulting services, AmerisourceBergen delivers innovative programs and solutions across the pharmaceutical supply channel in human and animal health. Through our daily work—and powered by our 22,000 associates—we are united in our responsibility to create healthier futures. AmerisourceBergen is ranked #10 on the Fortune 500, with more than $185 billion in annual revenue.